nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyclothiazide—SLC12A1—urine—germ cell cancer	0.0514	0.113	CbGeAlD
Methyclothiazide—SLC12A1—appendage—germ cell cancer	0.05	0.11	CbGeAlD
Methyclothiazide—SLC12A1—ganglion—germ cell cancer	0.035	0.0773	CbGeAlD
Methyclothiazide—CA4—ganglion—germ cell cancer	0.0188	0.0416	CbGeAlD
Methyclothiazide—SLC12A1—telencephalon—germ cell cancer	0.0135	0.0298	CbGeAlD
Methyclothiazide—CA4—neck—germ cell cancer	0.0107	0.0237	CbGeAlD
Methyclothiazide—CA1—eye—germ cell cancer	0.0102	0.0225	CbGeAlD
Methyclothiazide—Vasculitis—Ifosfamide—germ cell cancer	0.0101	0.0184	CcSEcCtD
Methyclothiazide—Aplastic anaemia—Dactinomycin—germ cell cancer	0.0101	0.0184	CcSEcCtD
Methyclothiazide—SLC12A1—spinal cord—germ cell cancer	0.00947	0.0209	CbGeAlD
Methyclothiazide—CA1—telencephalon—germ cell cancer	0.0093	0.0205	CbGeAlD
Methyclothiazide—Hyperuricaemia—Cisplatin—germ cell cancer	0.00913	0.0167	CcSEcCtD
Methyclothiazide—CA2—neck—germ cell cancer	0.00889	0.0196	CbGeAlD
Methyclothiazide—Pulmonary oedema—Ifosfamide—germ cell cancer	0.00874	0.016	CcSEcCtD
Methyclothiazide—Blood uric acid increased—Cisplatin—germ cell cancer	0.00862	0.0158	CcSEcCtD
Methyclothiazide—SLC12A1—head—germ cell cancer	0.00842	0.0186	CbGeAlD
Methyclothiazide—Hyperuricaemia—Etoposide—germ cell cancer	0.00836	0.0153	CcSEcCtD
Methyclothiazide—CA4—brainstem—germ cell cancer	0.00819	0.0181	CbGeAlD
Methyclothiazide—SLC12A1—testis—germ cell cancer	0.00813	0.0179	CbGeAlD
Methyclothiazide—Blood uric acid increased—Etoposide—germ cell cancer	0.0079	0.0144	CcSEcCtD
Methyclothiazide—Haemolytic anaemia—Ifosfamide—germ cell cancer	0.0079	0.0144	CcSEcCtD
Methyclothiazide—CA2—trigeminal ganglion—germ cell cancer	0.00768	0.0169	CbGeAlD
Methyclothiazide—CA2—embryo—germ cell cancer	0.00741	0.0164	CbGeAlD
Methyclothiazide—CA4—telencephalon—germ cell cancer	0.00727	0.016	CbGeAlD
Methyclothiazide—Agranulocytosis—Vinblastine—germ cell cancer	0.0071	0.013	CcSEcCtD
Methyclothiazide—Haemolytic anaemia—Cisplatin—germ cell cancer	0.00681	0.0124	CcSEcCtD
Methyclothiazide—CA2—brainstem—germ cell cancer	0.00679	0.015	CbGeAlD
Methyclothiazide—CA2—eye—germ cell cancer	0.00661	0.0146	CbGeAlD
Methyclothiazide—CA2—retina—germ cell cancer	0.00655	0.0145	CbGeAlD
Methyclothiazide—CA1—bone marrow—germ cell cancer	0.00655	0.0144	CbGeAlD
Methyclothiazide—CA1—spinal cord—germ cell cancer	0.00652	0.0144	CbGeAlD
Methyclothiazide—Pneumonia—Bleomycin—germ cell cancer	0.00647	0.0118	CcSEcCtD
Methyclothiazide—SLC12A1—brain—germ cell cancer	0.0061	0.0135	CbGeAlD
Methyclothiazide—Pancreatitis—Ifosfamide—germ cell cancer	0.00604	0.011	CcSEcCtD
Methyclothiazide—Pneumonia—Dactinomycin—germ cell cancer	0.00603	0.011	CcSEcCtD
Methyclothiazide—CA2—telencephalon—germ cell cancer	0.00603	0.0133	CbGeAlD
Methyclothiazide—Stevens-Johnson syndrome—Dactinomycin—germ cell cancer	0.00594	0.0109	CcSEcCtD
Methyclothiazide—CA4—pituitary gland—germ cell cancer	0.00592	0.0131	CbGeAlD
Methyclothiazide—CA1—endocrine gland—germ cell cancer	0.00587	0.0129	CbGeAlD
Methyclothiazide—CA1—head—germ cell cancer	0.00579	0.0128	CbGeAlD
Methyclothiazide—CA2—skin of body—germ cell cancer	0.00575	0.0127	CbGeAlD
Methyclothiazide—CA2—decidua—germ cell cancer	0.00571	0.0126	CbGeAlD
Methyclothiazide—CA4—medulla oblongata—germ cell cancer	0.00571	0.0126	CbGeAlD
Methyclothiazide—Orthostatic hypotension—Cisplatin—germ cell cancer	0.00561	0.0103	CcSEcCtD
Methyclothiazide—Agranulocytosis—Dactinomycin—germ cell cancer	0.00559	0.0102	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Ifosfamide—germ cell cancer	0.00556	0.0102	CcSEcCtD
Methyclothiazide—Cramp muscle—Cisplatin—germ cell cancer	0.00553	0.0101	CcSEcCtD
Methyclothiazide—Pneumonia—Ifosfamide—germ cell cancer	0.00553	0.0101	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Ifosfamide—germ cell cancer	0.00545	0.00996	CcSEcCtD
Methyclothiazide—Vertigo—Vinblastine—germ cell cancer	0.00534	0.00977	CcSEcCtD
Methyclothiazide—Leukopenia—Vinblastine—germ cell cancer	0.00532	0.00974	CcSEcCtD
Methyclothiazide—CA4—adrenal gland—germ cell cancer	0.00529	0.0117	CbGeAlD
Methyclothiazide—CA4—midbrain—germ cell cancer	0.00522	0.0115	CbGeAlD
Methyclothiazide—Pancreatitis—Cisplatin—germ cell cancer	0.00521	0.00952	CcSEcCtD
Methyclothiazide—Agranulocytosis—Ifosfamide—germ cell cancer	0.00513	0.00937	CcSEcCtD
Methyclothiazide—CA4—bone marrow—germ cell cancer	0.00512	0.0113	CbGeAlD
Methyclothiazide—CA4—spinal cord—germ cell cancer	0.00509	0.0112	CbGeAlD
Methyclothiazide—Erythema multiforme—Dactinomycin—germ cell cancer	0.00509	0.0093	CcSEcCtD
Methyclothiazide—Cramp muscle—Etoposide—germ cell cancer	0.00507	0.00927	CcSEcCtD
Methyclothiazide—Hyperuricaemia—Methotrexate—germ cell cancer	0.00501	0.00916	CcSEcCtD
Methyclothiazide—CA4—female gonad—germ cell cancer	0.00493	0.0109	CbGeAlD
Methyclothiazide—CA2—pituitary gland—germ cell cancer	0.00491	0.0108	CbGeAlD
Methyclothiazide—Vasculitis—Methotrexate—germ cell cancer	0.00476	0.0087	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Vinblastine—germ cell cancer	0.00475	0.00869	CcSEcCtD
Methyclothiazide—CA2—medulla oblongata—germ cell cancer	0.00474	0.0105	CbGeAlD
Methyclothiazide—Blood uric acid increased—Methotrexate—germ cell cancer	0.00473	0.00865	CcSEcCtD
Methyclothiazide—Erythema multiforme—Ifosfamide—germ cell cancer	0.00466	0.00853	CcSEcCtD
Methyclothiazide—Anorexia—Vinblastine—germ cell cancer	0.00463	0.00846	CcSEcCtD
Methyclothiazide—CA4—endocrine gland—germ cell cancer	0.00459	0.0101	CbGeAlD
Methyclothiazide—CA4—head—germ cell cancer	0.00453	0.00999	CbGeAlD
Methyclothiazide—Leukopenia—Bleomycin—germ cell cancer	0.0045	0.00822	CcSEcCtD
Methyclothiazide—CA2—adrenal gland—germ cell cancer	0.00438	0.00968	CbGeAlD
Methyclothiazide—CA4—testis—germ cell cancer	0.00437	0.00965	CbGeAlD
Methyclothiazide—Pneumonia—Etoposide—germ cell cancer	0.00436	0.00798	CcSEcCtD
Methyclothiazide—Aplastic anaemia—Methotrexate—germ cell cancer	0.00436	0.00798	CcSEcCtD
Methyclothiazide—Paraesthesia—Vinblastine—germ cell cancer	0.00436	0.00797	CcSEcCtD
Methyclothiazide—CA2—midbrain—germ cell cancer	0.00433	0.00955	CbGeAlD
Methyclothiazide—Stevens-Johnson syndrome—Etoposide—germ cell cancer	0.0043	0.00787	CcSEcCtD
Methyclothiazide—Malnutrition—Ifosfamide—germ cell cancer	0.00429	0.00785	CcSEcCtD
Methyclothiazide—CA2—bone marrow—germ cell cancer	0.00424	0.00936	CbGeAlD
Methyclothiazide—Jaundice—Etoposide—germ cell cancer	0.00423	0.00773	CcSEcCtD
Methyclothiazide—CA2—spinal cord—germ cell cancer	0.00422	0.00932	CbGeAlD
Methyclothiazide—Decreased appetite—Vinblastine—germ cell cancer	0.00422	0.00772	CcSEcCtD
Methyclothiazide—CA1—brain—germ cell cancer	0.0042	0.00926	CbGeAlD
Methyclothiazide—Leukopenia—Dactinomycin—germ cell cancer	0.00419	0.00767	CcSEcCtD
Methyclothiazide—Constipation—Vinblastine—germ cell cancer	0.00415	0.00759	CcSEcCtD
Methyclothiazide—Pulmonary oedema—Methotrexate—germ cell cancer	0.00414	0.00756	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Bleomycin—germ cell cancer	0.0041	0.0075	CcSEcCtD
Methyclothiazide—CA2—female gonad—germ cell cancer	0.00409	0.00902	CbGeAlD
Methyclothiazide—CA1—lymph node—germ cell cancer	0.00406	0.00895	CbGeAlD
Methyclothiazide—Agranulocytosis—Etoposide—germ cell cancer	0.00405	0.0074	CcSEcCtD
Methyclothiazide—Vision blurred—Ifosfamide—germ cell cancer	0.00405	0.0074	CcSEcCtD
Methyclothiazide—CA4—cerebellum—germ cell cancer	0.00404	0.00891	CbGeAlD
Methyclothiazide—Thrombocytopenia—Bleomycin—germ cell cancer	0.00401	0.00734	CcSEcCtD
Methyclothiazide—Agitation—Ifosfamide—germ cell cancer	0.00395	0.00721	CcSEcCtD
Methyclothiazide—Anorexia—Bleomycin—germ cell cancer	0.00391	0.00715	CcSEcCtD
Methyclothiazide—Vertigo—Ifosfamide—germ cell cancer	0.00386	0.00705	CcSEcCtD
Methyclothiazide—Leukopenia—Ifosfamide—germ cell cancer	0.00384	0.00703	CcSEcCtD
Methyclothiazide—Photosensitivity—Methotrexate—germ cell cancer	0.00384	0.00702	CcSEcCtD
Methyclothiazide—CA2—endocrine gland—germ cell cancer	0.0038	0.00839	CbGeAlD
Methyclothiazide—CA2—head—germ cell cancer	0.00375	0.00828	CbGeAlD
Methyclothiazide—Thrombocytopenia—Dactinomycin—germ cell cancer	0.00374	0.00685	CcSEcCtD
Methyclothiazide—Malnutrition—Cisplatin—germ cell cancer	0.0037	0.00677	CcSEcCtD
Methyclothiazide—Erythema multiforme—Etoposide—germ cell cancer	0.00368	0.00673	CcSEcCtD
Methyclothiazide—Paraesthesia—Bleomycin—germ cell cancer	0.00368	0.00673	CcSEcCtD
Methyclothiazide—Anorexia—Dactinomycin—germ cell cancer	0.00364	0.00666	CcSEcCtD
Methyclothiazide—CA2—testis—germ cell cancer	0.00363	0.008	CbGeAlD
Methyclothiazide—Hypersensitivity—Vinblastine—germ cell cancer	0.00358	0.00654	CcSEcCtD
Methyclothiazide—Decreased appetite—Bleomycin—germ cell cancer	0.00356	0.00652	CcSEcCtD
Methyclothiazide—Muscle spasms—Cisplatin—germ cell cancer	0.00356	0.00651	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Ifosfamide—germ cell cancer	0.0035	0.00641	CcSEcCtD
Methyclothiazide—Vision blurred—Cisplatin—germ cell cancer	0.00349	0.00638	CcSEcCtD
Methyclothiazide—Asthenia—Vinblastine—germ cell cancer	0.00348	0.00637	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00343	0.00627	CcSEcCtD
Methyclothiazide—CA2—cerebellum—germ cell cancer	0.00335	0.00739	CbGeAlD
Methyclothiazide—Anorexia—Ifosfamide—germ cell cancer	0.00334	0.00611	CcSEcCtD
Methyclothiazide—Decreased appetite—Dactinomycin—germ cell cancer	0.00332	0.00608	CcSEcCtD
Methyclothiazide—Diarrhoea—Vinblastine—germ cell cancer	0.00332	0.00607	CcSEcCtD
Methyclothiazide—Leukopenia—Cisplatin—germ cell cancer	0.00331	0.00606	CcSEcCtD
Methyclothiazide—CA4—brain—germ cell cancer	0.00328	0.00724	CbGeAlD
Methyclothiazide—Muscle spasms—Etoposide—germ cell cancer	0.00326	0.00596	CcSEcCtD
Methyclothiazide—Urticaria—Bleomycin—germ cell cancer	0.00326	0.00596	CcSEcCtD
Methyclothiazide—Body temperature increased—Bleomycin—germ cell cancer	0.00324	0.00593	CcSEcCtD
Methyclothiazide—Dizziness—Vinblastine—germ cell cancer	0.00321	0.00587	CcSEcCtD
Methyclothiazide—CA4—lymph node—germ cell cancer	0.00317	0.007	CbGeAlD
Methyclothiazide—Paraesthesia—Ifosfamide—germ cell cancer	0.00315	0.00575	CcSEcCtD
Methyclothiazide—Vomiting—Vinblastine—germ cell cancer	0.00309	0.00564	CcSEcCtD
Methyclothiazide—Vertigo—Etoposide—germ cell cancer	0.00305	0.00557	CcSEcCtD
Methyclothiazide—Decreased appetite—Ifosfamide—germ cell cancer	0.00305	0.00557	CcSEcCtD
Methyclothiazide—Headache—Vinblastine—germ cell cancer	0.00304	0.00556	CcSEcCtD
Methyclothiazide—Leukopenia—Etoposide—germ cell cancer	0.00304	0.00555	CcSEcCtD
Methyclothiazide—Body temperature increased—Dactinomycin—germ cell cancer	0.00302	0.00553	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Cisplatin—germ cell cancer	0.00302	0.00552	CcSEcCtD
Methyclothiazide—Hypersensitivity—Bleomycin—germ cell cancer	0.00302	0.00552	CcSEcCtD
Methyclothiazide—Constipation—Ifosfamide—germ cell cancer	0.003	0.00548	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Cisplatin—germ cell cancer	0.00296	0.00541	CcSEcCtD
Methyclothiazide—Asthenia—Bleomycin—germ cell cancer	0.00294	0.00538	CcSEcCtD
Methyclothiazide—Nausea—Vinblastine—germ cell cancer	0.00288	0.00527	CcSEcCtD
Methyclothiazide—Anorexia—Cisplatin—germ cell cancer	0.00288	0.00527	CcSEcCtD
Methyclothiazide—Pancreatitis—Methotrexate—germ cell cancer	0.00286	0.00523	CcSEcCtD
Methyclothiazide—Hypersensitivity—Dactinomycin—germ cell cancer	0.00282	0.00515	CcSEcCtD
Methyclothiazide—Urticaria—Ifosfamide—germ cell cancer	0.00278	0.00509	CcSEcCtD
Methyclothiazide—Body temperature increased—Ifosfamide—germ cell cancer	0.00277	0.00506	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Etoposide—germ cell cancer	0.00277	0.00506	CcSEcCtD
Methyclothiazide—Asthenia—Dactinomycin—germ cell cancer	0.00274	0.00502	CcSEcCtD
Methyclothiazide—CA2—brain—germ cell cancer	0.00272	0.006	CbGeAlD
Methyclothiazide—Paraesthesia—Cisplatin—germ cell cancer	0.00271	0.00496	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Etoposide—germ cell cancer	0.00271	0.00495	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Methotrexate—germ cell cancer	0.00266	0.00487	CcSEcCtD
Methyclothiazide—Anorexia—Etoposide—germ cell cancer	0.00264	0.00482	CcSEcCtD
Methyclothiazide—CA2—lymph node—germ cell cancer	0.00263	0.0058	CbGeAlD
Methyclothiazide—Decreased appetite—Cisplatin—germ cell cancer	0.00263	0.0048	CcSEcCtD
Methyclothiazide—Diarrhoea—Dactinomycin—germ cell cancer	0.00262	0.00478	CcSEcCtD
Methyclothiazide—Pneumonia—Methotrexate—germ cell cancer	0.00261	0.00478	CcSEcCtD
Methyclothiazide—Vomiting—Bleomycin—germ cell cancer	0.00261	0.00477	CcSEcCtD
Methyclothiazide—Rash—Bleomycin—germ cell cancer	0.00258	0.00473	CcSEcCtD
Methyclothiazide—Dermatitis—Bleomycin—germ cell cancer	0.00258	0.00472	CcSEcCtD
Methyclothiazide—Hypersensitivity—Ifosfamide—germ cell cancer	0.00258	0.00472	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.00258	0.00471	CcSEcCtD
Methyclothiazide—Asthenia—Ifosfamide—germ cell cancer	0.00251	0.0046	CcSEcCtD
Methyclothiazide—Paraesthesia—Etoposide—germ cell cancer	0.00248	0.00454	CcSEcCtD
Methyclothiazide—Nausea—Bleomycin—germ cell cancer	0.00244	0.00445	CcSEcCtD
Methyclothiazide—Vomiting—Dactinomycin—germ cell cancer	0.00243	0.00445	CcSEcCtD
Methyclothiazide—Agranulocytosis—Methotrexate—germ cell cancer	0.00243	0.00443	CcSEcCtD
Methyclothiazide—Rash—Dactinomycin—germ cell cancer	0.00241	0.00441	CcSEcCtD
Methyclothiazide—Decreased appetite—Etoposide—germ cell cancer	0.00241	0.0044	CcSEcCtD
Methyclothiazide—Diarrhoea—Ifosfamide—germ cell cancer	0.0024	0.00438	CcSEcCtD
Methyclothiazide—Body temperature increased—Cisplatin—germ cell cancer	0.00239	0.00437	CcSEcCtD
Methyclothiazide—Constipation—Etoposide—germ cell cancer	0.00237	0.00433	CcSEcCtD
Methyclothiazide—Dizziness—Ifosfamide—germ cell cancer	0.00232	0.00424	CcSEcCtD
Methyclothiazide—Nausea—Dactinomycin—germ cell cancer	0.00227	0.00415	CcSEcCtD
Methyclothiazide—Vomiting—Ifosfamide—germ cell cancer	0.00223	0.00407	CcSEcCtD
Methyclothiazide—Hypersensitivity—Cisplatin—germ cell cancer	0.00223	0.00407	CcSEcCtD
Methyclothiazide—Rash—Ifosfamide—germ cell cancer	0.00221	0.00404	CcSEcCtD
Methyclothiazide—Dermatitis—Ifosfamide—germ cell cancer	0.00221	0.00404	CcSEcCtD
Methyclothiazide—Erythema multiforme—Methotrexate—germ cell cancer	0.00221	0.00403	CcSEcCtD
Methyclothiazide—Urticaria—Etoposide—germ cell cancer	0.0022	0.00402	CcSEcCtD
Methyclothiazide—Body temperature increased—Etoposide—germ cell cancer	0.00219	0.004	CcSEcCtD
Methyclothiazide—Asthenia—Cisplatin—germ cell cancer	0.00217	0.00396	CcSEcCtD
Methyclothiazide—Nausea—Ifosfamide—germ cell cancer	0.00208	0.00381	CcSEcCtD
Methyclothiazide—Diarrhoea—Cisplatin—germ cell cancer	0.00207	0.00378	CcSEcCtD
Methyclothiazide—Hypersensitivity—Etoposide—germ cell cancer	0.00204	0.00373	CcSEcCtD
Methyclothiazide—Malnutrition—Methotrexate—germ cell cancer	0.00203	0.00371	CcSEcCtD
Methyclothiazide—Asthenia—Etoposide—germ cell cancer	0.00199	0.00363	CcSEcCtD
Methyclothiazide—Vomiting—Cisplatin—germ cell cancer	0.00192	0.00351	CcSEcCtD
Methyclothiazide—Vision blurred—Methotrexate—germ cell cancer	0.00191	0.0035	CcSEcCtD
Methyclothiazide—Rash—Cisplatin—germ cell cancer	0.0019	0.00348	CcSEcCtD
Methyclothiazide—Dermatitis—Cisplatin—germ cell cancer	0.0019	0.00348	CcSEcCtD
Methyclothiazide—Diarrhoea—Etoposide—germ cell cancer	0.00189	0.00346	CcSEcCtD
Methyclothiazide—Dizziness—Etoposide—germ cell cancer	0.00183	0.00335	CcSEcCtD
Methyclothiazide—Vertigo—Methotrexate—germ cell cancer	0.00182	0.00334	CcSEcCtD
Methyclothiazide—Leukopenia—Methotrexate—germ cell cancer	0.00182	0.00332	CcSEcCtD
Methyclothiazide—Nausea—Cisplatin—germ cell cancer	0.00179	0.00328	CcSEcCtD
Methyclothiazide—Vomiting—Etoposide—germ cell cancer	0.00176	0.00322	CcSEcCtD
Methyclothiazide—Rash—Etoposide—germ cell cancer	0.00174	0.00319	CcSEcCtD
Methyclothiazide—Dermatitis—Etoposide—germ cell cancer	0.00174	0.00319	CcSEcCtD
Methyclothiazide—Headache—Etoposide—germ cell cancer	0.00173	0.00317	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Methotrexate—germ cell cancer	0.00166	0.00303	CcSEcCtD
Methyclothiazide—Nausea—Etoposide—germ cell cancer	0.00164	0.00301	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Methotrexate—germ cell cancer	0.00162	0.00297	CcSEcCtD
Methyclothiazide—Anorexia—Methotrexate—germ cell cancer	0.00158	0.00289	CcSEcCtD
Methyclothiazide—Paraesthesia—Methotrexate—germ cell cancer	0.00149	0.00272	CcSEcCtD
Methyclothiazide—Decreased appetite—Methotrexate—germ cell cancer	0.00144	0.00263	CcSEcCtD
Methyclothiazide—Urticaria—Methotrexate—germ cell cancer	0.00132	0.00241	CcSEcCtD
Methyclothiazide—Body temperature increased—Methotrexate—germ cell cancer	0.00131	0.0024	CcSEcCtD
Methyclothiazide—Hypersensitivity—Methotrexate—germ cell cancer	0.00122	0.00223	CcSEcCtD
Methyclothiazide—Asthenia—Methotrexate—germ cell cancer	0.00119	0.00217	CcSEcCtD
Methyclothiazide—Diarrhoea—Methotrexate—germ cell cancer	0.00113	0.00207	CcSEcCtD
Methyclothiazide—Dizziness—Methotrexate—germ cell cancer	0.0011	0.002	CcSEcCtD
Methyclothiazide—Vomiting—Methotrexate—germ cell cancer	0.00105	0.00193	CcSEcCtD
Methyclothiazide—Rash—Methotrexate—germ cell cancer	0.00105	0.00191	CcSEcCtD
Methyclothiazide—Dermatitis—Methotrexate—germ cell cancer	0.00104	0.00191	CcSEcCtD
Methyclothiazide—Headache—Methotrexate—germ cell cancer	0.00104	0.0019	CcSEcCtD
Methyclothiazide—Nausea—Methotrexate—germ cell cancer	0.000985	0.0018	CcSEcCtD
